Extramural venous invasion (EMVI) revisited: a detailed analysis of various characteristics of EMVI and their role as a predictive imaging biomarker in the neoadjuvant treatment response in rectal cancer

Purpose To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma. Methods 57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuv...

Full description

Saved in:
Bibliographic Details
Published inAbdominal imaging Vol. 47; no. 6; pp. 1975 - 1987
Main Authors Altinmakas, Emre, Dogan, Hakan, Taskin, Orhun Cig, Ozoran, Emre, Bugra, Dursun, Adsay, Volkan, Balik, Emre, Gurses, Bengi
Format Journal Article
LanguageEnglish
Published New York Springer US 01.06.2022
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN2366-0058
2366-004X
2366-0058
DOI10.1007/s00261-022-03495-4

Cover

Abstract Purpose To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma. Methods 57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach. Results At initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p  < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces. Conclusion This study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably “intravascular.” Graphical abstract
AbstractList To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma. 57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach. At initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces. This study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably "intravascular."
Purpose To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma. Methods 57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach. Results At initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p  < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces. Conclusion This study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably “intravascular.” Graphical abstract
To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma.PURPOSETo assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma.57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach.METHODS57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach.At initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces.RESULTSAt initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces.This study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably "intravascular."CONCLUSIONThis study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably "intravascular."
PurposeTo assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma.Methods57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach.ResultsAt initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces.ConclusionThis study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably “intravascular.”
Author Ozoran, Emre
Dogan, Hakan
Balik, Emre
Taskin, Orhun Cig
Altinmakas, Emre
Bugra, Dursun
Adsay, Volkan
Gurses, Bengi
Author_xml – sequence: 1
  givenname: Emre
  orcidid: 0000-0002-0727-9230
  surname: Altinmakas
  fullname: Altinmakas, Emre
  organization: Department of Radiology, Koç University School of Medicine, Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai
– sequence: 2
  givenname: Hakan
  orcidid: 0000-0003-2613-0228
  surname: Dogan
  fullname: Dogan, Hakan
  organization: Department of Radiology, Koç University School of Medicine
– sequence: 3
  givenname: Orhun Cig
  orcidid: 0000-0002-6668-3006
  surname: Taskin
  fullname: Taskin, Orhun Cig
  organization: Department of Pathology, Koç University School of Medicine
– sequence: 4
  givenname: Emre
  orcidid: 0000-0002-9371-6811
  surname: Ozoran
  fullname: Ozoran, Emre
  organization: Department of General Surgery, Koç University School of Medicine
– sequence: 5
  givenname: Dursun
  orcidid: 0000-0003-0316-6818
  surname: Bugra
  fullname: Bugra, Dursun
  organization: Department of General Surgery, Koç University School of Medicine
– sequence: 6
  givenname: Volkan
  orcidid: 0000-0002-1308-3701
  surname: Adsay
  fullname: Adsay, Volkan
  organization: Department of Pathology, Koç University School of Medicine
– sequence: 7
  givenname: Emre
  orcidid: 0000-0001-5751-1133
  surname: Balik
  fullname: Balik, Emre
  organization: Department of General Surgery, Koç University School of Medicine
– sequence: 8
  givenname: Bengi
  orcidid: 0000-0002-2482-3445
  surname: Gurses
  fullname: Gurses, Bengi
  email: bgurses@kuh.ku.edu.tr
  organization: Department of Radiology, Koç University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35332398$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNUREvpH-CALHEph4A_Yu8uN1QtUKmIC3CNZu3J1ktiL2Mnor-RP4XTLR_qoSeP7OedeeV5n1ZHIQasqueCvxacL94kzqURNZey5qpZ6bp5VJ1IZUzNuV4e_VcfV2cp7TjnwmghpH5SHSutlFSr5Un1a_0zEwwjQc8mDHFMzIcJko-Bna8_fbt8xQgnn3xG95YBc5jB9-gYBOhvkk8sdmwC8rPSXgOBzUg-ZW9vn-YWhXUsX6MnRrFHBqk02hM6b7OfkPkBtj5s2cbHAeg7UrEw8yxgBLcbJwiZZULIA5aKMO1jSDhThDYX5xaCRXpWPe6gT3h2d55WX9-vv1x8rK8-f7i8eHdVW8V1rp0UunHQbQSsOom6seWGm6W1xjhjtezUBoyVGxSrhXZLrY20YiHRoFAauTqtzg999xR_jJhyO_hkse-hGB5TK03TcKlkIwr68h66iyOVr5sp05QBUspCvbijxs2Art1T-RK6af-sqQDyAFiKKRF2fxHB2zkO7SEObYlDexuHtimi5T2R9Rly2WzZuO8flqqDNJU5YYv0z_YDqt_FFMvt
CitedBy_id crossref_primary_10_1007_s00261_022_03590_6
crossref_primary_10_3390_jpm12081344
crossref_primary_10_1016_j_ejrad_2025_112005
crossref_primary_10_1053_j_ro_2024_12_003
crossref_primary_10_1007_s00261_024_04556_6
crossref_primary_10_1007_s13304_023_01744_9
crossref_primary_10_1007_s00261_022_03617_y
crossref_primary_10_1148_radiol_230079
crossref_primary_10_1007_s00261_024_04203_0
Cites_doi 10.1007/s00261-018-1673-2
10.5152/dir.2018.17286
10.1007/s11888-016-0319-4
10.1111/j.1365-2559.1981.tb01774.x
10.1111/codi.14106
10.1038/bjc.2017.99
10.1148/radiol.2018172889
10.3390/cancers10090319
10.2214/AJR.15.15568
10.4137/CMO.S370
10.1007/s11888-016-0321-x
10.1002/jso.25064
10.1148/radiol.2341031403
10.1038/bjc.2013.603
10.1007/s00330-014-3527-9
10.3348/kjr.2017.18.1.132
10.1148/radiol.2322021326
10.1016/j.crad.2014.01.010
10.1002/bjs.5917
10.1093/annonc/mdu029
10.21614/sgo-25-1-22
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
– notice: 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
DBID AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
JQ2
K7-
K9.
KB0
LK8
M0S
M1P
M7P
M7Z
NAPCQ
P5Z
P62
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00261-022-03495-4
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Computer Science Collection
ProQuest Central Essentials
ProQuest : Biological Science Collection journals [unlimited simultaneous users]
ProQuest Central
Technology Collection
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Computer Science Collection
Computer Science Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Biochemistry Abstracts 1
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Computer Science Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Computer Science Collection
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Biochemistry Abstracts 1
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Computer Science Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2366-0058
EndPage 1987
ExternalDocumentID 35332398
10_1007_s00261_022_03495_4
Genre Journal Article
GroupedDBID -EM
04C
0R~
29~
2J2
2JN
2JY
2KG
2KM
2LR
406
53G
5VS
7RV
7X7
88E
8AO
8FH
8FI
8FJ
95-
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAYIU
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHVE
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AEOHA
AESKC
AEVLU
AEXYK
AFBBN
AFEXP
AFJLC
AFKRA
AFLOW
AFQWF
AFRAH
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGVAE
AGWZB
AGYKE
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AILAN
AITGF
AJBLW
AJOOF
AJRNO
AJZVZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AOCGG
ARAPS
ARMRJ
AXYYD
AZFZN
B-.
BBNVY
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BMSDO
BSONS
CCPQU
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIHBH
EIOEI
EJD
EMB
EMOBN
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
GGCAI
GNWQR
GRRUI
H13
HCIFZ
HMCUK
IKXTQ
IMOTQ
ITM
IWAJR
J-C
JZLTJ
K7-
KOV
LK8
LLZTM
M1P
M4Y
M7P
NAPCQ
NPVJJ
NQJWS
NU0
O9J
PQQKQ
PROAC
PSQYO
PT4
QOR
R89
ROL
RSV
S16
SCLPG
SDE
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
TSG
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VFIZW
W23
YLTOR
Z7X
Z83
Z87
Z8V
Z8W
Z91
ZMTXR
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PUEGO
NPM
---
.86
.VR
06C
06D
0VY
1N0
23M
2~H
30V
36B
3V.
4.4
408
409
40D
40E
5GY
5RE
67Z
6NX
7XB
8FD
8FE
8FG
8FK
8TC
95.
95~
96X
AAWCG
AAWTL
AAYQN
ABBXA
ABOCM
ACOMO
ADHIR
ADIMF
AEGAL
AENEX
AEPYU
AETLH
AFWTZ
AHAVH
AIIXL
AKMHD
ALWAN
AZQEC
BA0
BKEYQ
BPHCQ
BVXVI
CS3
DL5
DWQXO
ESBYG
EX3
F5P
FEDTE
FR3
G-Y
G-Z
GGRSB
GJIRD
GNUQQ
GQ7
GQ8
GXS
HF~
HG5
HMJXF
HQYDN
HRMNR
HVGLF
I09
IHE
IJ-
IXC
IZIGR
IZQ
I~Z
J0Z
JQ2
K6V
K9.
KDC
KPH
LAS
M7Z
MA-
N9A
NB0
O93
O9I
OAM
OVD
P19
P62
P64
P9S
PF0
PKEHL
PQEST
PQUKI
PRINS
Q2X
QOK
QOS
R9I
RHV
RPX
RRX
S27
S37
S3B
SAP
SDH
SHX
SMD
T13
TSV
TT1
TUC
U2A
U9L
VC2
WH7
WJK
WK8
WOW
Z45
ZOVNA
7X8
ID FETCH-LOGICAL-c305t-d2154dafb1a9f2e54cd21068cc66d6c52f3ba6c2be1975d85562c172e6e135e03
IEDL.DBID BENPR
ISSN 2366-0058
2366-004X
IngestDate Fri Sep 05 14:18:56 EDT 2025
Mon Oct 06 17:07:10 EDT 2025
Mon Jul 21 06:00:36 EDT 2025
Wed Oct 01 02:53:15 EDT 2025
Thu Apr 24 23:00:20 EDT 2025
Fri Feb 21 02:45:02 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords EMVI
MRI
Rectum
Cancer
Language English
License 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c305t-d2154dafb1a9f2e54cd21068cc66d6c52f3ba6c2be1975d85562c172e6e135e03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2613-0228
0000-0003-0316-6818
0000-0002-1308-3701
0000-0001-5751-1133
0000-0002-2482-3445
0000-0002-9371-6811
0000-0002-6668-3006
0000-0002-0727-9230
PMID 35332398
PQID 2664197222
PQPubID 31175
PageCount 13
ParticipantIDs proquest_miscellaneous_2644023241
proquest_journals_2664197222
pubmed_primary_35332398
crossref_primary_10_1007_s00261_022_03495_4
crossref_citationtrail_10_1007_s00261_022_03495_4
springer_journals_10_1007_s00261_022_03495_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220600
2022-06-00
2022-Jun
20220601
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 6
  year: 2022
  text: 20220600
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Abdominal imaging
PublicationTitleAbbrev Abdom Radiol
PublicationTitleAlternate Abdom Radiol (NY)
PublicationYear 2022
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Siddiqui, Simillis, Hunter (CR13) 2017; 116
Ale Ali, Kirsch, Razaz, Jhaveri, Thipphavong, Kennedy, Jhaveri (CR5) 2019; 44
Cho, Park, Yoon, Yang, Baik, Lee, Kim, Kim (CR14) 2018; 117
Sohn, Lim, Kim, Myoung, Choi, Kim, Kim (CR9) 2015; 25
Jhaveri, Hosseini-Nik, Thipphavong, Assarzadegan, Menezes, Kennedy, Kirsch (CR17) 2016; 206
Zhang, Wang, Li, Wang, Shi, Wang, Wu, Sun (CR6) 2018; 289
Balyasnikova, Brown (CR19) 2016; 12
Talbot, Ritchie, Leighton, Hughes, Bussey, Morson (CR8) 1981; 5
Kong, Guerra, Warrier, Lynch, Michael, Ngan, Phillips, Ramsay, Heriot (CR11) 2018; 20
Sclafani, Brown (CR1) 2016; 12
Gomes, Pereira, Oliveira, Nogueira, Oliveria, Pereira, Costa, Martins (CR2) 2019; 25
Bugg, Andreou, Biswas, Toms, Williams (CR20) 2014; 69
Chand, Bhangu, Wotherspoon, Stamp, Swift, Chau, Tekkis, Brown (CR4) 2014; 25
(CR7) 2017; 18
Chand, Swift, Tekkis, Chau, Brown (CR21) 2014; 110
Beets-Tan, Beets (CR3) 2004; 232
Koh, Smith, Swift, Brown (CR16) 2008; 2
Sun, Li, Shen, Wang, Tong, Gu (CR18) 2018; 24
Smith, Barbachano, Norman, Swift, Abulafi, Brown (CR15) 2008; 95
Vliegen, Beets, von Meyenfeldt, Kessels, Lemaire, van Engelshoven, Beets-Tan (CR12) 2005; 234
Song, Chung, Kang, Kim, Oh, Lee, Kim, Lee, Kim, Kim (CR10) 2018; 10
Roy FA Vliegen (3495_CR12) 2005; 234
DM Koh (3495_CR16) 2008; 2
XY Zhang (3495_CR6) 2018; 289
MRS Siddiqui (3495_CR13) 2017; 116
B Sohn (3495_CR9) 2015; 25
WG Bugg (3495_CR20) 2014; 69
M Chand (3495_CR4) 2014; 25
IC Talbot (3495_CR8) 1981; 5
F Sclafani (3495_CR1) 2016; 12
MS Cho (3495_CR14) 2018; 117
NJ Smith (3495_CR15) 2008; 95
KS Jhaveri (3495_CR17) 2016; 206
H Ale Ali (3495_CR5) 2019; 44
KSAR Study Group for Rectal Cancer (3495_CR7) 2017; 18
JC Kong (3495_CR11) 2018; 20
Y Sun (3495_CR18) 2018; 24
S Balyasnikova (3495_CR19) 2016; 12
C Song (3495_CR10) 2018; 10
M Chand (3495_CR21) 2014; 110
RG Beets-Tan (3495_CR3) 2004; 232
AR Gomes (3495_CR2) 2019; 25
References_xml – volume: 44
  start-page: 1
  year: 2019
  end-page: 10
  ident: CR5
  article-title: Extramural venous invasion in rectal cancer: overview of imaging, histopathology, and clinical implications
  publication-title: Abdom Radiol (NY)
  doi: 10.1007/s00261-018-1673-2
– volume: 24
  start-page: 128
  year: 2018
  end-page: 134
  ident: CR18
  article-title: Predictive value of MRI-detected extramural vascular invasion in stage T3 rectal cancer patients before neoadjuvant chemoradiation
  publication-title: Diagn Interv Radiol
  doi: 10.5152/dir.2018.17286
– volume: 12
  start-page: 130
  year: 2016
  end-page: 140
  ident: CR1
  article-title: Extramural Venous Invasion (EMVI) and Tumour Regression Grading (TRG) as Potential Prognostic Factors for Risk Stratification and Treatment Decision in Rectal Cancer
  publication-title: Curr Colorectal Cancer Rep
  doi: 10.1007/s11888-016-0319-4
– volume: 5
  start-page: 141
  year: 1981
  end-page: 163
  ident: CR8
  article-title: Invasion of veins by carcinoma of rectum: method of detection, histological features and significance
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.1981.tb01774.x
– volume: 20
  start-page: 574
  year: 2018
  end-page: 585
  ident: CR11
  article-title: Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis
  publication-title: Colorectal Dis
  doi: 10.1111/codi.14106
– volume: 116
  start-page: 1513
  year: 2017
  end-page: 1519
  ident: CR13
  article-title: A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2017.99
– volume: 289
  start-page: 677
  year: 2018
  end-page: 685
  ident: CR6
  article-title: MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival
  publication-title: Radiology
  doi: 10.1148/radiol.2018172889
– volume: 10
  start-page: 319
  year: 2018
  ident: CR10
  article-title: Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers10090319
– volume: 206
  start-page: 747
  year: 2016
  end-page: 755
  ident: CR17
  article-title: MRI Detection of Extramural Venous Invasion in Rectal Cancer: Correlation With Histopathology Using Elastin Stain
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.15.15568
– volume: 2
  start-page: 267
  year: 2008
  end-page: 273
  ident: CR16
  article-title: The Relationship Between MR Demonstration of Extramural Venous Invasion and Nodal Disease in Rectal Cancer
  publication-title: Clin Med Oncol
  doi: 10.4137/CMO.S370
– volume: 12
  start-page: 162
  year: 2016
  end-page: 169
  ident: CR19
  article-title: Imaging Advances in Colorectal Cancer
  publication-title: Curr Colorectal Cancer Rep
  doi: 10.1007/s11888-016-0321-x
– volume: 117
  start-page: 1823
  year: 2018
  end-page: 1832
  ident: CR14
  article-title: MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery
  publication-title: J Surg Oncol
  doi: 10.1002/jso.25064
– volume: 234
  start-page: 179
  issue: 1
  year: 2005
  end-page: 188
  ident: CR12
  article-title: Rectal Cancer: MR Imaging in Local Staging—Is Gadolinium-based Contrast Material Helpful?
  publication-title: Radiology
  doi: 10.1148/radiol.2341031403
– volume: 110
  start-page: 19
  year: 2014
  end-page: 25
  ident: CR21
  article-title: Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2013.603
– volume: 25
  start-page: 1347
  year: 2015
  end-page: 1355
  ident: CR9
  article-title: MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer
  publication-title: Eur Radiol
  doi: 10.1007/s00330-014-3527-9
– volume: 18
  start-page: 132
  year: 2017
  end-page: 151
  ident: CR7
  article-title: Essential Items for Structured Reporting of Rectal Cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal Radiology
  publication-title: Korean J Radiol
  doi: 10.3348/kjr.2017.18.1.132
– volume: 232
  start-page: 335
  issue: 2
  year: 2004
  end-page: 346
  ident: CR3
  article-title: Rectal cancer: review with emphasis on MR imaging
  publication-title: Radiology
  doi: 10.1148/radiol.2322021326
– volume: 69
  start-page: 619
  year: 2014
  end-page: 623
  ident: CR20
  article-title: The prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma
  publication-title: Clin Radiol
  doi: 10.1016/j.crad.2014.01.010
– volume: 95
  start-page: 229
  year: 2008
  end-page: 236
  ident: CR15
  article-title: Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer
  publication-title: Journal of British Surgery
  doi: 10.1002/bjs.5917
– volume: 25
  start-page: 858
  year: 2014
  end-page: 863
  ident: CR4
  article-title: EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdu029
– volume: 25
  start-page: 22
  year: 2019
  end-page: 29
  ident: CR2
  article-title: Extramural Venous Invasion in Rectal Cancer: Relationship between Magnetic Resonance Imaging Demonstration and Histopathological Results
  publication-title: Surg Gastroenterol Oncol
  doi: 10.21614/sgo-25-1-22
– volume: 44
  start-page: 1
  year: 2019
  ident: 3495_CR5
  publication-title: Abdom Radiol (NY)
  doi: 10.1007/s00261-018-1673-2
– volume: 234
  start-page: 179
  issue: 1
  year: 2005
  ident: 3495_CR12
  publication-title: Radiology
  doi: 10.1148/radiol.2341031403
– volume: 110
  start-page: 19
  year: 2014
  ident: 3495_CR21
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2013.603
– volume: 289
  start-page: 677
  year: 2018
  ident: 3495_CR6
  publication-title: Radiology
  doi: 10.1148/radiol.2018172889
– volume: 117
  start-page: 1823
  year: 2018
  ident: 3495_CR14
  publication-title: J Surg Oncol
  doi: 10.1002/jso.25064
– volume: 18
  start-page: 132
  year: 2017
  ident: 3495_CR7
  publication-title: Korean J Radiol
  doi: 10.3348/kjr.2017.18.1.132
– volume: 24
  start-page: 128
  year: 2018
  ident: 3495_CR18
  publication-title: Diagn Interv Radiol
  doi: 10.5152/dir.2018.17286
– volume: 25
  start-page: 1347
  year: 2015
  ident: 3495_CR9
  publication-title: Eur Radiol
  doi: 10.1007/s00330-014-3527-9
– volume: 20
  start-page: 574
  year: 2018
  ident: 3495_CR11
  publication-title: Colorectal Dis
  doi: 10.1111/codi.14106
– volume: 25
  start-page: 22
  year: 2019
  ident: 3495_CR2
  publication-title: Surg Gastroenterol Oncol
  doi: 10.21614/sgo-25-1-22
– volume: 95
  start-page: 229
  year: 2008
  ident: 3495_CR15
  publication-title: Journal of British Surgery
  doi: 10.1002/bjs.5917
– volume: 206
  start-page: 747
  year: 2016
  ident: 3495_CR17
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.15.15568
– volume: 69
  start-page: 619
  year: 2014
  ident: 3495_CR20
  publication-title: Clin Radiol
  doi: 10.1016/j.crad.2014.01.010
– volume: 116
  start-page: 1513
  year: 2017
  ident: 3495_CR13
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2017.99
– volume: 2
  start-page: 267
  year: 2008
  ident: 3495_CR16
  publication-title: Clin Med Oncol
  doi: 10.4137/CMO.S370
– volume: 10
  start-page: 319
  year: 2018
  ident: 3495_CR10
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers10090319
– volume: 12
  start-page: 162
  year: 2016
  ident: 3495_CR19
  publication-title: Curr Colorectal Cancer Rep
  doi: 10.1007/s11888-016-0321-x
– volume: 232
  start-page: 335
  issue: 2
  year: 2004
  ident: 3495_CR3
  publication-title: Radiology
  doi: 10.1148/radiol.2322021326
– volume: 12
  start-page: 130
  year: 2016
  ident: 3495_CR1
  publication-title: Curr Colorectal Cancer Rep
  doi: 10.1007/s11888-016-0319-4
– volume: 5
  start-page: 141
  year: 1981
  ident: 3495_CR8
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.1981.tb01774.x
– volume: 25
  start-page: 858
  year: 2014
  ident: 3495_CR4
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdu029
SSID ssj0001651125
ssj0008379
Score 2.383296
Snippet Purpose To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy...
To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response...
PurposeTo assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1975
SubjectTerms Adenocarcinoma
Biomarkers
Blood vessels
Cancer
Cancer therapies
Colorectal cancer
Discordance
Elastin
Evaluation
Gastroenterology
Hepatology
Hollow Organ GI
Imaging
Magnetic resonance imaging
Medical imaging
Medicine
Medicine & Public Health
Pathology
Patients
Radiology
Rectum
Sensitivity
Tumors
Veins
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7BVkJcypsGCjISBxCkWie2SbhVaEsBLScWlVPkV6QCzVbZ7ArxF_lTzDhOoBSQeo3HziQzcT57Zj4DPFZTYxEIu9RKNIOw-TQtipKnPivwAve1q6l2eP5eHS7E2yN5FIvCVkO2-xCSDDP1WOwWlgspZZ8Tp4pMxWXYCnxbE9jaf_3p3W97K4pghIw1Mn_vfPY_dA5cnguMhv_NwTVYDJr2aSZf9tad2bPf_yBxvOijXIftCEDZfu8xN-CSb27ClXkMsd-CH7NvXatPiI2DbQKBKztuNpo21diT2fzjm6esDRXpCFVfMs36HFTvmI70JmxZsw2uwKmnPUsHTU00BMo6FkIUjLIbmV7hQKct6UCzLzs-CWcnMeIGoPShFlUgedb4pXaf14j-OzamyKM-Ic_XkxRN4Ki5JWdub8PiYPbh1WEaT3xI0UlklzoEIMLp2nBd1pmXwuKVqSqsVcopK7M6N1rZzHhevpCukIjeLEIwrzzPpZ_md2DSLBu_A8xw9DIEI0Y6JTgvTamzUuMoeWlNLm0CfLB_ZSMdOp3K8bUaiZyDlSq0UhWsVIkEno19TnsykP9K7w5uVcWJYVUhHhJ00luWJfBobMZPmuI0Gt_immQEruoR6fIE7vbuON4uR3hOlI0JPB9c69fg_9bl3sXE78PVLHgn7TbtwqRr1_4Bgq_OPIzf2k_hKye8
  priority: 102
  providerName: Springer Nature
Title Extramural venous invasion (EMVI) revisited: a detailed analysis of various characteristics of EMVI and their role as a predictive imaging biomarker in the neoadjuvant treatment response in rectal cancer
URI https://link.springer.com/article/10.1007/s00261-022-03495-4
https://www.ncbi.nlm.nih.gov/pubmed/35332398
https://www.proquest.com/docview/2664197222
https://www.proquest.com/docview/2644023241
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 2366-0058
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001651125
  issn: 2366-0058
  databaseCode: AFBBN
  dateStart: 19970201
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: ProQuest Technology Collection
  customDbUrl:
  eissn: 2366-0058
  dateEnd: 20241103
  omitProxy: true
  ssIdentifier: ssj0008379
  issn: 2366-0058
  databaseCode: 8FG
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/technologycollection1
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 2366-0058
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001651125
  issn: 2366-0058
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 2366-0058
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0008379
  issn: 2366-0058
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ta9RAEB7aOxC_iO-m1mMFPygaTDa7aSKI9CTXqtwhYuX8FDa7G6jY3DXNHf5H_5Qzm5dSiv2SQDLZG25md5_dnXkG4EUcFBqBsPG1RDMIHQV-kqShb3mCD0JbmpJyh-eL-PhEfF7K5Q4s-lwYCqvsx0Q3UJuVpj3ytziRCCqRxfmH9blPVaPodLUvoaG60grmvaMY24UxJ2asEYyn2eLrt2FsTlr2PR7FuI4OxLJLo3HJdG454lN0O3G2SF9cnaqu4c9rZ6duSprdhTsdlmSHrfHvwY6t7sOteXda_gD-Zn-aWp0RsQbbOi5WdlptFe2PsZfZ_MenV6x2yeWIOt8xxdpwUmuY6phK2KpkW1xM05f6KrMzvaImUNYwd9rAKFCRqQtsaF2TDjSQstMzVwaJUZo_RQLVqALJs8qulPm1QSDfsCHaHfVxIbuWpGgsRs01-WX9EE5m2fePx35XvMFHe8vGN4glhFFlEaq05FYKjU-CONE6jk2sJS-jQsWaFxatKk0iEYhpRFM2tmEkbRA9glG1quwTYEWIDoO4opAGfSBMi1TxVGErUaqLSGoPwt5Oue6YzanAxu984GR2ts3RtrmzbS48eD18s255PW6U3u_Nn3d9_CK_9EgPng-vsXfSkYvCf3FDMgIX6AhaQw8et24z_FyESJvYFz140_vRZeP_12XvZl2ewm3ufJg2ivZh1NQb-wxxU1NMYPdgeYDXZHY0gfHhbDpd0P3o55ds0nWUf_gsGrI
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwEB2VVoK-IO4NFDASSCCISBw7SpAqxGWrXdpdIdRW-xYc25GKaHbJZhf4OX6An2LGuVRVRd_6mtjOKDOeiz1zBuBpHOQaHWHja4lsEDoK_CRJQ9_yBB-EtjAF1Q6PJ_HwUHyayuka_OlqYSitstOJTlGbmaYz8tdoSAS1yOL87fyHT12j6Ha1a6Gh2tYKZsdBjLWFHXv2908M4RY7o4_I72ec7w4OPgz9tsuAj4TJ2jdo9IRRRR6qtOBWCo1PgjjROo5NrCUvolzFmucWPy9NItFj0Gj2bWzDSNogwnWvwIaIRIrB38b7weTzl94WJA3aH49ijNsDMW3Ldlzxngt_fMqmJ4wY6YuzpvGcv3vurtaZwN0bcL31Xdm7Rthuwpotb8HVcXs7fxv-Dn7VlTohIA-2ctiv7LhcKTqPY88H46PRC1a5Ynb0ct8wxZr0VWuYapFR2KxgKwzeaaY-iyRNr2gJHGuYu91glBjJ1AIXmldEAyludnzi2i4xghWgzKMKSaDxrLQzZb4tMXCoWZ9dj_S4FGFLo0j3I-Wa9kF1Bw4vhY13Yb2clXYLWB6igKIfk0uDMhemeap4qnCVKNV5JLUHYcenTLdI6tTQ43vWY0A73mbI28zxNhMevOznzBsckQtHb3fsz1qdsshOd4AHT_rXqA3oikfhX1zSGCECcpJDD-41YtN_LkLPntAePXjVydHp4v-n5f7FtDyGa8OD8X62P5rsPYBN7uSZDqm2Yb2ulvYh-mx1_qjdGAy-XvZe_AdZ7VLT
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB9qheKL-G1q1RUUFA1N9iNNBBGxd_SsV3ywcm_pZncDFZu75nKn_mv-C_5TzuwlKaXYt74mu5MhMzsfu7O_AXieRIXBQNiGRqEYpBFRmKZZHDqe4oPYlbaku8Pjg2TvUH6aqMka_OnuwlBZZWcTvaG2U0N75NvoSCS1yOJ8u2zLIr7sDt_PTkPqIEUnrV07jZWK7LvfPzF9m78b7aKsX3A-HHz9uBe2HQZCZEo1oUWHJ60ui1hnJXdKGnwSJakxSWITo3gpCp0YXjj8tLKpwmjBoMt3iYuFcpFAutfg-o4QGZUT7kz6ZA8jG4_zx0WCGXskJ-2FHX9tzyc-IdXREzqMCuV5p3gh0r1wSuud3_AW3GyjVvZhpWa3Yc1Vd2Bj3J7L34W_g19NrU8IwoMtPeorO66Wmnbi2MvB-NvoFav9NXaMb98yzVaFq84y3WKisGnJlpi200xzHkOaXhEJHGuZP9dgVBLJ9BwJzWrigUw2Oz7xDZcYAQpQzVGNLNB4Vrmptt8XmDI0rK-rR358cbCjUWT1kXNDK6C-B4dXIsT7sF5NK_cQWBGjamIEUyiL2hZnRaZ5ppGKyEwhlAkg7uSUmxZDnVp5_Mh79Gcv2xxlm3vZ5jKA1_2c2QpB5NLRW53489aazPMz3Q_gWf8a7QAd7mj8iwsaI2VE4XEcwIOV2vSfExjTE85jAG86PToj_n9eNi_n5Sls4ArMP48O9h_BDe7VmXantmC9qRfuMQZrTfHErwoGR1e9DP8BDydQbQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extramural+venous+invasion+%28EMVI%29+revisited%3A+a+detailed+analysis+of+various+characteristics+of+EMVI+and+their+role+as+a+predictive+imaging+biomarker+in+the+neoadjuvant+treatment+response+in+rectal+cancer&rft.jtitle=Abdominal+radiology+%28New+York%29&rft.au=Altinmakas%2C+Emre&rft.au=Dogan%2C+Hakan&rft.au=Taskin%2C+Orhun+Cig&rft.au=Ozoran%2C+Emre&rft.date=2022-06-01&rft.issn=2366-0058&rft.eissn=2366-0058&rft.volume=47&rft.issue=6&rft.spage=1975&rft_id=info:doi/10.1007%2Fs00261-022-03495-4&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2366-0058&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2366-0058&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2366-0058&client=summon